Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Linnemann, C.C.
Perlstein, P.H.
Ramundo, N.
Minton, S.D.
Englender, G.S.
McCormick, J.B.
and
Hayes, P.S.
1975.
USE OF PERTUSSIS VACCINE IN AN EPIDEMIC INVOLVING HOSPITAL STAFF.
The Lancet,
Vol. 306,
Issue. 7934,
p.
540.
1977.
Whooping-cough Vacillation.
The Lancet,
Vol. 310,
Issue. 8028,
p.
71.
Pittman, Margaret
Gardner, Roberta A.
and
Marshall, James F.
1979.
Evaluation of the potency of antipertussis serum products.
Journal of Biological Standardization,
Vol. 7,
Issue. 3,
p.
263.
macaulay, Margaret E.
1979.
The serological diagnosis of whooping cough.
Journal of Hygiene,
Vol. 83,
Issue. 1,
p.
95.
Solimano, Giorgio
and
Lederman, Sally A.
1979.
Nutrition.
p.
447.
Goodman, Y E
Wort, A J
and
Jackson, F L
1981.
Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection.
Journal of Clinical Microbiology,
Vol. 13,
Issue. 2,
p.
286.
Ashworth, L. A. E.
Fitzgeorge, R. B.
Irons, L. I.
Morgan, C. P.
and
Robinson, A.
1982.
Rabbit nasopharyngeal colonization byBordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.
Journal of Hygiene,
Vol. 88,
Issue. 3,
p.
475.
Burstyn, D G
Baraff, L J
Peppler, M S
Leake, R D
St Geme, J
and
Manclark, C R
1983.
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis.
Infection and Immunity,
Vol. 41,
Issue. 3,
p.
1150.
Robinson, A.
Irons, L.I.
and
Ashworth, L.A.E.
1985.
Pertussis vaccine: present status and future prospects.
Vaccine,
Vol. 3,
Issue. 1,
p.
11.
Ashworth, L. A. E.
and
Robinson, A.
1989.
Recent Developments in Prophylactic Immunization.
p.
1.
Brennan, Michael J.
Burns, Drusilla L.
Meade, Bruce D.
Shahin, Roberta D.
and
Manclark, Charles R.
1992.
Vaccines.
p.
23.
Shahin, R D
Amsbaugh, D F
and
Leef, M F
1992.
Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.
Infection and Immunity,
Vol. 60,
Issue. 4,
p.
1482.
Roberts, Mark
Cropley, Ian
Chatfield, Steve
and
Dougan, Gordon
1993.
Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHA.
Vaccine,
Vol. 11,
Issue. 8,
p.
866.
Herland Berstad, Aud Katrine
Holst, Johan
Møgster, Bente
Lise Haugen, Inger
and
Haneberg, Bjørn
1997.
A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin.
Vaccine,
Vol. 15,
Issue. 12-13,
p.
1473.
Haneberg, Bjørn
and
Holst, Johan
2002.
Can nonliving nasal vaccines be made to work?.
Expert Review of Vaccines,
Vol. 1,
Issue. 2,
p.
227.
Locht, Camille
and
Mielcarek, Nathalie
2012.
New pertussis vaccination approaches: en route to protect newborns?.
FEMS Immunology & Medical Microbiology,
Vol. 66,
Issue. 2,
p.
121.
Solans, Luis
and
Locht, Camille
2019.
The Role of Mucosal Immunity in Pertussis.
Frontiers in Immunology,
Vol. 9,
Issue. ,
Dubois, Violaine
and
Locht, Camille
2021.
Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives.
Frontiers in Immunology,
Vol. 12,
Issue. ,
Locht, Camille
2021.
The Path to New Pediatric Vaccines against Pertussis.
Vaccines,
Vol. 9,
Issue. 3,
p.
228.
Blanchard-Rohner, Geraldine
2022.
Novel approaches to reactivate pertussis immunity.
Expert Review of Vaccines,
Vol. 21,
Issue. 12,
p.
1787.